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Abstract
Background: The Golgi apparatus in mammals appears as a ribbon made up of interconnected
stacks of flattened cisternae that is positioned close to the centrosome in a microtubule-dependent
manner. How this organisation is achieved and retained is not well understood. GMAP210 is a long
coiled-coil cis-Golgi associated protein that plays a role in maintaining Golgi ribbon integrity and
position and contributes to the formation of the primary cilium. An amphipathic alpha-helix able to
bind liposomes in vitro has been recently identified at the first 38 amino acids of the protein
(amphipathic lipid-packing sensor motif), and an ARF1-binding domain (Grip-related Arf-binding
domain) was found at the C-terminus. To which type of membranes these two GMAP210 regions
bind  in vivo and how this contributes to GMAP210 localisation and function remains to be
investigated.
Results: By using truncated as well as chimeric mutants and videomicroscopy we found that both
the N-terminus and the C-terminus of GMAP210 are targeted to the cis-Golgi in vivo. The ALPS
motif was identified as the N-terminal binding motif and appeared concentrated in the periphery of
Golgi elements and between Golgi stacks. On the contrary, the C-terminal domain appeared
uniformly distributed in the cis-cisternae of the Golgi apparatus. Strikingly, the two ends of the
protein also behave differently in response to the drug Brefeldin A. The N-terminal domain
redistributed to the endoplasmic reticulum (ER) exit sites, as does the full-length protein, whereas
the C-terminal domain rapidly dissociated from the Golgi apparatus to the cytosol. Mutants
comprising the full-length protein but lacking one of the terminal motifs also associated with the
cis-Golgi with distribution patterns similar to those of the corresponding terminal end whereas a
mutant consisting in fused N- and C-terminal ends exhibits identical localisation as the endogenous
protein.
Conclusion: We conclude that the Golgi localisation of GMAP210 is the result of the combined
action of the two N- and C-terminal domains that recognise different sub-regions of the cis-GA.
Based on present and previous data, we propose a model in which GMAP210 would participate in
homotypic fusion of cis-cisternae by anchoring the surface of cisternae via its C-terminus and
projecting its distal N-terminus to bind the rims or to stabilise tubular structures connecting
neighbouring cis-cisternae.
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Background
In mammalian cells, the Golgi apparatus (GA) is com-
posed of stacks of cisternae laterally linked by tubules to
create a membrane network, the Golgi ribbon, whose for-
mation depends on its unique pericentrosomal position
[1,2]. Microtubules (MTs) play an important role in main-
taining integrity and positioning of the Golgi ribbon,
which is severely altered when MTs are depolymerised or
when minus-end directed motors are inactivated [3-5].
Maintaining the architecture of the Golgi ribbon also
requires continuous input of membranes from the ER [6]
and regulated lateral fusion of analogous cisternae [7].
Recent work has begun to identify components necessary
for linking cisternal stacks into a contiguous Golgi ribbon
[6-8]. Depletion of Golgi associated proteins such as
Golgin160 or GMAP210 has been shown to also disrupt
formation of the Golgi ribbon [9].
GMAP210 was first identified as a cis-Golgi associated
protein that redistributed to the intermediate compart-
ment (or to ER exit sites) in the presence of Brefeldin A
(BFA) [10]. We and others have shown that GMAP210 co-
sedimented with taxol-purified MTs [11,12] and its over-
expression profoundly perturbed, not only GA structure
and function, but also MT-network organisation [12]. We
further reported that GMAP210 co-precipitated γ-TuSC
and was able to recruit γtubulin to Golgi surface in a C-ter-
minus-dependent manner. When targeted to the mito-
chondria surface, GMAP210 induced their redistribution
to a pericentrosomal location [13]. In addition,
GMAP210 depletion by siRNA resulted in extensive frag-
mentation of the GA. Based on these data, we proposed
that by combining MT-anchoring and membrane fusion
activities GMAP210 contributes to Golgi ribbon forma-
tion around the centrosome [13]. We also identified a
Golgi-targeting signal in the N-terminus of GMAP210.
However, others failed to observe Golgi localisation of the
N-terminus but identified a Grip-related Arf-binding
domain (GRAB domain) at the C-terminus that interacts
with Golgi membranes [14]. Mutation of a leucine residue
predicted to be critical for GRAB-Arf binding abolished
GA recruitment of the C-terminal domain of GMAP210.
However, the effect of this mutation on the full-length
protein localisation was not investigated. In addition,
interaction with Arf1 has only been demonstrated in vitro
[15] and, the behaviour of GMAP210 in response to BFA
is not compatible with a simple Arf1-dependent Golgi
association. The existence of two Golgi-targeting motifs in
GMAP210 sequence has been recently confirmed [16].
A bioinformatics search has recently revealed the presence
of an ALPS (amphipathic lipid-packing sensor) motif at
the first 38 residues of GMAP210 [17]. The ALPS motif, a
lipid-binding module first identified in ArfGAP1 [18], is
unstructured in solution but folds into an α-helix once
bound to highly curved membranes. Because of this
behaviour, this motif is considered as a membrane curva-
ture sensor. An analysis of attachment properties of
GMAP210 N- or C-termini to liposomes revealed different
requirements: N-terminus preferably bound to small lipo-
somes whereas the C-terminus was recruited to liposomes
in an Arf1-GTP-dependent, size-independent manner.
Since ArfGAP1 displays curvature-dependent ArfGAP
activity in vitro, it would be expected that Arf1-GTP is con-
fined to flat membranes where ArfGAP activity is rather
low. Accordingly, addition of recombinant Arf-GAP1
decreased the association of the GMAP210 C-terminus to
small liposomes [15]. Based on these data, and on fluores-
cence and electron microscopy, a model was proposed in
which by tethering positively curved membranes via its N-
terminus to flat membranes via its C-terminus GMAP210
could serve to capture small transport vesicles in the inter-
face ER-Golgi. Other studies have recently reported that
Arf1-GTP is able to induce positive curvature through the
insertion of its N-terminal amphipathic helix in the lipid
bilayer, in a similar manner to the small GTPase Sar1p. In
this latter model, Arf1-GTP would be membrane-associ-
ated in positive-curvature regions where it could recruit
effector molecules [19-21].
The mechanism of membrane binding based on the detec-
tion of membrane curvature is likely to be relevant to
GMAP210 function. However, the physiological pathway
in which it is used remains to be characterised. Immu-
nolectron microscopy has revealed enrichment of
GMAP210 in curved regions of the cis-Golgi but has not
revealed binding of GMAP210 to any type of vesicles
either in mammalian [10,22] or in Drosophila cells [23].
Moreover, depletion of GMAP210 did not affect secretion
in both systems [9,23]. On the contrary, overexpression of
the protein profoundly disturbed Golgi structure, and
Golgi proteins from different compartments including
GMAP210 were found in vesicle clusters distributed
throughout the cell. Under these conditions, anterograde
and retrograde transport pathways were blocked [22,23]
although this effect could be secondary to the Golgi struc-
ture perturbation.
Recent studies have identified new GMAP210 partners.
Those include the small GTPase rab2 that interacts with
dGMAP in a coiled-coil region close to the C-terminus
[24] and the ciliary assembly protein IFT20. rab2 is local-
ised to the cis-GA and has been found to bind MTs and to
recruit dynein to membranes [25]. IFT20 is one of the
Intraflagellar Transport Proteins required for the assembly
of the primary cilium, and the only one that is localised to
the GA, in addition to the centrosome and the cilium [26].
GMAP210 mutant mice are viable until birth, when they
die from a pleiotrophic phenotype that includes growth
retardation and lung and heart defects [16]. Those miceBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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cannot be considered knockout mice sensu stricto since
they express a truncated form of the protein consisting of
the first 196 amino acids. This polypeptide includes the
ALPS motif and therefore the possibility that it could
interfere with membrane dynamics in vivo should be
taken into account. Cells from GMAP210 mutant mice
were able to form cilia but they were shorter than normal
and contained less polycystin-2 than those detected in
control cell lines. In mutant cells the IFT20 protein level is
also reduced. Whether defects of GMAP210 mutant mice
are due to a role of the protein in ciliary assembly through
anchoring IFT20, as proposed, or to additional functions
remain to be determined.
Finally, cells derived from GMAP210 mutant mice appar-
ently exhibited a normal Golgi. This is in marked contrast
with our previous results of RNAi-mediated inhibition of
GMAP210 expression in HeLa cells [13] and with those
recently published by the Linstedt group: in this study,
GMAP210 was identified in a siRNA screeening as a com-
ponent whose knockdown significantly fragmented and
dispersed the GA [9]. Depletion of GMAP210 yielded a
phenotype in which peri-centrosomal positioning of the
GA was disrupted, the Golgi ribbon was fragmented into
ministacks similar to those present in nocodazole-treated
cells, but secretion exhibited normal kinetics. Strikingly,
these cells completely failed to polarise and migrate in
wound-healing assays. A role of GMAP210 in minus-end
directed motility of Golgi membranes has been proposed.
All available data are consistent with GMAP210 having at
least two membrane targeting motifs. However, how these
motifs determine the GMAP210 localisation in vivo
remain unclear. We have now performed a detailed anal-
ysis of Golgi binding properties of GMAP210 by generat-
ing a battery of truncated and fusion mutants. We have
analysed their behaviour in non-transformed RPE1 cells
under several conditions applying optical microscopy and
video-recording approaches.
Results
The GMAP210 N-terminal domain is targeted to the cis-
Golgi and the ERES
As previously reported in other cell types, the N-terminal
domain of GMAP210 in fusion with GFP (Nter-GFP, 1–
375 aas) appeared Golgi-associated in RPE1 cells as
revealed by double labelling for the cis-Golgi protein
GM130, or the TGN-associated protein Golgin245 (Figure
1A). For analysis purposes, we selected cells with compa-
rable low expression levels in all our experiments. High
resolution images revealed that GFP labelling was not uni-
form and the fusion protein seemed to accumulate at spe-
cific sites (Figure 1A1, enlarged view). Fluorescence
intensity profiles along lines drawn over the Golgi area
showed the degree of co-localisation of each pair of pro-
teins (Figure 1A, bottom panels). Nter-GFP co-distributed
with GM130, but not with Golgin245, indicating that the
N-terminus of GMAP210 specifically targets the cis-side of
the GA. The cis-Golgi localisation of the Nter-GFP protein
was preserved after nocodazole-induced disruption of the
Golgi ribbon (Figure 1B) indicating that targeting of the
N-terminal domain to the cis-Golgi does not depend on
Golgi ribbon integrity.
To address the dynamics of GMAP210 N-terminal
domain in living cells, we generated a DsRed fusion pro-
tein (Nter-DsRed) and transfected it in an RPE1 cell line
stably expressing the transmembrane domain of galactos-
yltransferase fused to GFP (GT™-GFP; see also Additional
file 1). A spotty distribution of the Nter-DsRed fusion pro-
tein at the periphery of Golgi elements could be appreci-
ated (Figure 1C). In addition, it appeared enriched in
regions that seem to bridge two adjacent elements (Figure
1C, arrows). Note that DsRed-tagged N-terminal domain,
like Nter-GFP fusion protein, unevenly distributed on
Golgi membranes (compare enlarged views of Figures
1A1 and 1C).
Since GMAP210 dimerise [27], we wanted to exclude the
possibility that Golgi binding was due to association with
endogenous protein. To do this, we transfected the Nter-
GFP construct in GMAP210-silenced RPE1 cells by siRNA.
Decreasing concentrations of GMAP210 in RPE1 cells
fragmented the Golgi ribbon as in HeLa cells although ele-
ments remained closer to one another. Figure 1D shows a
non-depleted non-transfected (ND-NT), a depleted non-
transfected (D-NT) and a depleted transfected (D-T) cells.
As can be seen, the Nter-GFP protein was recruited to
Golgi elements even in the absence of endogenous
GMAP210.
Interestingly, some dots scattered throughout the cyto-
plasm that co-localised with Sec31 were also observed in
most cells, indicating that the Nter-GFP was also able to
bind ER exit sites (ERES; Figure 1E, arrows). In addition, it
re-localised to ERES upon BFA treatment (Figure 1F), a
behaviour that is reminiscent of that of the endogenous
GMAP210 protein [10]. Altogether, these data demon-
strate that GMAP210 N-terminal domain binds directly to
membranes in vivo, specifically targets the cis-Golgi and
can be recruited to ERES both in non-treated and in BFA-
treated cells.
The N-terminal cis-Golgi localisation signal corresponds to 
the ALPS motif
To define the module responsible for N-terminal domain
recruitment to membranes, we generated additional trun-
cated forms as shown in Figure 2A. The ALPS-like motif is
represented in red and coiled-coil regions in light blue.
The yellow rectangle corresponds to the continuousBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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The N-terminal domain of GMAP210 targets early compartments of the secretory pathway Figure 1
The N-terminal domain of GMAP210 targets early compartments of the secretory pathway. (A) Confocal 
images of RPE1 cells transfected with the Nter-GFP construct (A1) and double labelled for GM130 (A2, merged image) and 
Golgin245 (A3, merged image). An enlarged view of A1 is shown at the bottom. Insets show enlarged views. In bottom panels, 
fluorescence intensity profiles of lines drawn in insets are shown. (B) Nter-GFP transfected RPE1 cells treated with nocoda-
zole and stained for GM130 and Golgin245. Bottom panels show an enlarged view (left) and fluorescence intensity profiles 
(right) of the line drawn over a nocodazole-induced Golgi element. (C) Dynamics of the NterDsRed fusion protein in a RPE1 
cell line stably expressing GT™-GFP. Selected frames at the indicated times from Movie 1 (in Additional file 1) are shown. An 
enlarged view is shown at the bottom. Arrows point to sites in which the NterDsRed protein is located between two mem-
brane elements. (D) RPE1 cells treated with siRNA against GMAP210 for 72 h were transfected with the Nter-GFP construc-
tion (D1), incubated for 16 h and then fixed and immuno-stained for GM130 in red and GMAP210 in blue (D2). ND-NT 
indicates a non-depleted-non-transfected cell, D-NT a depleted non-transfected cell, and D-T a depleted and transfected cell. 
(E, F) Nter-GFP transfected cells (E) were treated with BFA (F) and then stained for Sec31 to reveal ER exit sites. Enlarged 
views of individual labellings are shown at right. Arrows indicate ERES containing the GMAP210 N-terminal domain. Bars = 5 
μmBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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coiled-coil domain used in the indicated constructs. West-
ern blot analysis of all truncated mutants revealed bands
with apparent sizes matching the predicted sizes (Figure
2B).
The 1-253-GFP exhibited identical GA localisation to the
whole N-terminal domain (1-375-GFP) (Figure 2C; com-
pare with Figure 1A). A construct containing only the first
76 amino acids weakly associated with GA (Figure 2D)
whereas no GA targeting was observed with the comple-
mentary mutant (76-253-GFP; Figure 3E). Finally, the first
38 amino acids of the protein, corresponding to the ALPS-
like motif, displayed good Golgi localisation that coin-
cided with GM130 (Figure 2F) and also decorated some
ERES (arrows in Figure 2F1). Surprisingly, this construct
showed a stronger Golgi binding than the 1-76-GFP one
(compare Figure 2D and Figure 2F; see below), suggesting
the presence of inhibitory sequences downstream of the
amphipathic helix.
We further examined the capacity of the ALPS-like motif
to target another polypeptide to GA in vivo, namely a seg-
ment of GMAP210 corresponding to a predicted continu-
ous coiled-coil with maximum probability to dimerise
(amino acid 389–630), that did not apparently contain
any targeting signal and was excluded from the nucleus
(Figure 2G). Two chimeric constructs, named 1–76CC
and ALPS-CC respectively, were expressed in fusion with
GFP. Addition of the coiled-coil fragment significantly
improved GA association of the ALPS sequence (Figure 2I)
but not that of the 1–76 one (Figure 2H). Quantification
of these experiments indicated that the affinity for Golgi
membranes of the ALPS-CC construct is 2.8 times higher
than of the 1–76CC fusion protein, which supports the
possibility of an inhibitory activity of aminoacids 38–76.
Strikingly, ALPS-CC showed a remarkably higher GA spe-
cificity than all the other constructs including the whole
N-terminal domain (compare Figure 1A and Figure 2I).
The construct was exclusively targeted to the GA and, in
fact, the distribution pattern of ALPS-CC was very similar
to that of the endogenous protein. The most likely expla-
nation is that the CC segment mediates the dimerisation
of the fusion protein, mimicking the structure of the wild-
type protein and increasing the avidity of the interaction
and the selectivity for cis-Golgi membranes. To support
this view we designed an additional construct in which
two ALPS-like motifs were placed in tandem separated by
a short break. As expected, this significantly increased GA
association (Figure 2J). These results conclusively demon-
strate that the ALPS motif is able to bind GA membranes
in the absence of any other targeting signal.
The remarkable specificity of the ALPS-CC construct
prompted us to analyse more closely the membrane-bind-
ing properties of this polypeptide. We compared the dis-
tribution of this chimeric protein with respect to that of
GM130 and Golgin245, in control (Figure 3A) or nocoda-
zole-treated (Figure 3B) cells. In enlarged views of insets,
pairs of labellings are as follows: GFP/Golgin245 label-
lings in left panels, GM130/Golgi245 labellings in middle
panels, triple labellings in right panels. Fluorescence
intensity profiles of lane 1 drawn over the Golgi area in
control cells show that the chimeric protein is specifically
targeted to the cis-Golgi (Figure 1A, bottom panel). A
careful examination revealed, however, that it was une-
venly distributed along the cis-side. GFP labelling
appeared concentrated in regions in which the intensity of
GM130 labelling was rather low. This was even more evi-
dent in individual Golgi ministacks generated by disrup-
tion of MTs (Figure 3B). An inverse correlation between
GFP and GM130 labellings in fluorescence intensity pro-
files was noted (lanes 2 and 3).
We conclude that the ALPS-like motif provides GMAP210
with a mechanism to specifically recognise and bind
membranes located at the cis-side of the GA. In addition,
it is specifically enriched in areas in which other mem-
brane-associated proteins such as GM130 are not present
(see below).
The C-terminal domain binds both cis-GA and centrosome
The binding properties of the GMAP210 C-terminal
domain (aas 1778–1979) have also been investigated.
Contrary to our previous results obtained in cold-metha-
nol COS fixed cells [12], PFA-fixed RPE1 cells displayed a
conspicuous GFP-labelling co-localising with GM130 and
endogenous GMAP210 at the GA (Figure 4A); in both
methanol and PFA-fixed cells an association with the cen-
trosome was detected (Figure 4B, arrows). Association of
the endogenous protein with the centrosome was not
observed, confirming our previous data on COS7 cells
[12]. Identical results were obtained when GFP-Cter was
transfected in GMAP210-silenced cells (Figure 4C). Strik-
ingly, confocal microscopy using markers of the cis-Golgi
(GM130; Figure 4D), the medial-Golgi (CTR433; Figure
4E) or the trans-Golgi network (Golgin-245; Figure 4F)
revealed also a specific recruitment of GFP-Cter to the cis
face of GA. In marked contrast with the N-terminal
domain, however, GFP-Cter distribution was continuous
along the ribbon.
When cells expressing the GFP-Cter construct were treated
with nocodazole, centrosomal GFP labelling disappeared
(not shown) whereas labelling remained on the scattered
Golgi elements (Figure 4G). To investigate the effects of
BFA on GFP-Cter membrane association, we employed a
time-lapse microscopy approach (Figure 4H; see also
Additional file 2). GFP-Cter rapidly dissociated from
membranes after BFA addition. Since BFA is an inhibitorBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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The ALPS motif of GMAP210 is sufficient for Golgi binding Figure 2
The ALPS motif of GMAP210 is sufficient for Golgi binding. (A, B) Schematic representation of the GFP-tagged N-
terminal domain of GMAP210 and all the truncated or fusion constructs in this domain that were tested for their binding to 
GA (A) and their migration on SDS-PAGE as revealed by Western blot with an anti-GFP antibody after expression in RPE1 
cells (B). The ALPS-like motif is represented in red and coiled-coil regions in light blue. The yellow rectangle corresponds to 
the continuous coiled-coil domain used in the indicated constructs. (C to J) Subcellular localisation of the different N-terminal 
mutants and other constructs (as indicated) expressed in RPE1 cells and double labelled for GM130. Arrows in (F1) indicate 
ERES. Bars = 10 μm.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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of Arf-specific guanine nucleotide exchange factors which
prevents GTP loading of Arf1, the behaviour of the C-ter-
minal domain supports the possibility that GMAP210
could be an ARF1 effector (see below). On the contrary,
centrosomal labelling remained (arrow), suggesting that
molecular mechanisms mediating the association of this
domain with GA or centrosome are distinct.
Membrane binding motifs of GMAP210 distribute 
differentially within GA
Cells were then co-transfected with Nter-DsRed and GFP-
Cter constructs and further fixed, labelled and analysed by
confocal microscopy (Figure 5A) or conventional immun-
ofluorescence (IF) followed by deconvolution (Figures 5B
and 5C). Only cells expressing low levels of both con-
structs were analysed. While both domains specifically
target the cis-GA, a clear segregation of both constructs
within GA was apparent (inset in Figure 5A) with the N-
terminal domain enriched in areas that seem to connect
adjacent elements (arrows). Segregation was also
observed with respect to giantin (Figure 5B) and, more
interestingly, to endogenous GMAP210 that remained
associated to Golgi membranes even in the presence of
both N- and C-terminal ends (Figure 5C). Treatment with
BFA of double transfected cells confirmed the different
redistribution of both ends of the protein: the C-terminal
domain dissociated from membranes, but not from the
centrosome, whereas the N-terminal domain redistrib-
uted to ERES (Figure 5D).
To trace the behaviour of GMAP210 terminal domains we
performed time-lapse analysis of double transfected RPE1
A detailed analysis of the distribution of the ALPS-CC mutant protein in Golgi membranes Figure 3
A detailed analysis of the distribution of the ALPS-CC mutant protein in Golgi membranes. (A, B) Cells trans-
fected with the ALPS-CC-GFP construct (A) were treated (B) with nocodazole and labelled with anti-GM130 and anti-
Golgin245 antibodies. Merged images are shown. Enlarged views of insets show merged images of GFP and Golgin245 labellings 
in left panels, merged images of GM130 and Golgin245 labellings in middle panels and merged images of the three labellings in 
right panels. At the bottom, fluorescence intensity profiles of lines drawn over Golgi membranes revealed cis-Golgi localisation 
of the mutant (lane 1) but also a striking enrichment in regions from which GM130 is excluded and vice versa (arrows and lanes 
2 and 3). Bars = 5 μm.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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The C-terminal region of GMAP210 targets the cis-Golgi compartment and the centrosome Figure 4
The C-terminal region of GMAP210 targets the cis-Golgi compartment and the centrosome. (A, B) RPE1 cells 
were transfected with the C-terminal domain of GMAP210 (aa 1778–1979) in fusion with GFP, fixed and double labelled for 
GM130 and endogenous GMAP210 (A) or for the centrosomal protein ninein and GMAP210 (B). Merged images are shown in 
A2 and B2. Arrows indicate the centrosome. (C) A merged image of GMAP210-depleted cells transfected with the GFP-Cter 
construct and stained for GM130 and endogenous GMAP210. ND-NT indicates a non-depleted non-transfected cell, D-NT a 
depleted non-transfected cell and D-T, a depleted and transfected cell. (D to F) Confocal images showing the distribution of 
GFP-Cter fusion protein with respect to the cis-Golgi marker GM130 (D), the medial Golgi marker CTR433 (E) or the trans-
Golgi marker Golgin 245 (F). Corresponding fluorescence intensity profiles are shown at right. (G) A GFP-Cter transfected 
cell treated with nocodazole and labelled for GM130. Enlarged views of single labellings are shown at the bottom. (H) Live 
imaging of a GFP-Cter transfected cell treated with BFA. BFA was added to a final concentration of 2.5 μg/ml at time 5.0 sec-
onds and images were taken with 0.2-second intervals. Selected frames of Movie 2 (in Additional file 2) at indicated time points 
are shown. Note that GFP-Cter rapidly dissociated from membranes after BFA addition whereas fluorescence at the centro-
some decreased only slightly (arrow). Bars = 5 μm.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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cells (Figures 5E and 5F; see also Additional files 3 and 4).
We selected cells expressing similar levels of both trun-
cated mutants. Strikingly, in a 120 min interval of obser-
vation, the GA of control cells appeared unperturbed and
rather static (Figure 5E). As noted above, neither sepa-
rately nor simultaneously expressed, the terminal
domains displaced the endogenous GMAP210 protein
from membranes. The N-terminal domain mostly accu-
mulated between membrane elements containing the C-
terminal domain and seemed to bridge them in agree-
ment with IF results (enlarged view 1 at right). After noc-
odazole addition, the GA fragmented and Golgi
ministacks dispersed throughout the cytoplasm (Figure
5F). Individual Golgi ministacks contained both terminal
domains but they did not co-localise: the N-terminal
domain accumulated at the rims of the C-terminal con-
taining cis-cisternae (enlarged view 2 at right).
Taken together, these results suggest that both ends of
GMAP210 contribute to determine its localisation inside
the GA. To definitively demonstrate this hypothesis we
generated a new construct consisting of both terminal
domains expressed in fusion (Nter-Cter-GFP). The distri-
bution of this truncated mutant, which corresponds to the
full-length protein lacking the long central coiled-coil,
was almost identical to that of the endogenous GMAP210
in both control cells (Figure 5G) and isolated Golgi mini-
stacks induced by nocodazole treatment (Figure 5H;
arrows in enlarged view). We conclude that the localisa-
tion of GMAP210 is the result of the combined action of
both N- and C-terminal ends.
Both N-terminus or C-terminus are sufficient to target 
GMAP210 to the GA
Finally, to evaluate the contribution of each membrane-
binding domain to Golgi localisation of GMAP210, we
generated GFP-fused truncated forms lacking either one or
both, as represented in Figure 6A. Western blot analysis
showed that proteins of expected size were expressed in
transfected cells (Figure 6F). The mutant containing the C-
terminus but lacking the N-terminus (GFP-GMAPΔN)
accumulated at the GA as revealed by double labelling for
the cis-Golgi protein GM130, or the TGN-associated pro-
tein Golgin245 (Figure 6B). Fluorescence intensity pro-
files along lines drawn over the Golgi area showed that
GFP-GMAPΔN perfectly co-distributes with GM130, but
not with Golgin245, indicating that the truncated mutant
specifically binds the cis-side of the GA (Figure 6B, bot-
tom panels). In the same way, the truncated mutant lack-
ing the C-terminus (GFP-GMAPΔC) mostly localised to
the GA (Figure 6C) although its distribution pattern was
more complex. Similarly to the ALPS motif, it partially
overlapped with GM130 and did not co-localise with
Golgin245 (Figure 6C, bottom panels), indicating that it
was also specifically targeted to the cis-side of the GA. In
addition, the truncated mutant accumulated in some
Golgi regions and in some peripheral spotty structures
and tubules that did not contain GA markers. Finally, the
long central coiled-coil domain, divided into two differ-
ent fragments named CC1 (251–856) and CC2 (534–
1779), did not apparently associate with any subcellular
structure nor contribute to Golgi localisation in agree-
ment with the behaviour of Nter-Cter-GFP fusion protein
(Figures 6D and 6E).
Discussion
Our present data demonstrate that the cis-Golgi localisa-
tion of GMAP210 involves two distinct membrane bind-
ing motifs located at the ends of the protein. Although
both the N-terminal and the C-terminal domains specifi-
cally targeted the cis-GA, they did not co-localise nor did
they with the endogenous protein. In addition, they did
not displace the endogenous protein from the GA. How-
ever, when expressed in fusion as parts of the same
polypeptide, it exhibited an almost identical localisation
to the endogenous protein. Altogether these data support
localisation of GMAP210 being the result of the com-
bined action of the two ends of the protein that recognise
different domains of the cis-GA.
The N-terminal Golgi binding sequence exactly matches
the ALPS motif. This motif that has been reported to bind
lipids and to act as a curvature sensor in vitro [17] exhibits
a remarkable specificity in vivo: it accumulates at discrete
regions of the cis-cisternae and also associates with some
ER exit sites. Golgi binding significantly increased when
the ALPS motif was expressed in a dimeric form either by
expression in tandem (ALPS2-GFP) or by fusion with a
non-adjacent coiled-coil segment with the highest proba-
bility to dimerise including a leucine zipper (ALPS-CC-
GFP). The striking specificity of the latter construct (see
Figure 3) indicates that the ALPS motif of GMAP210 is
able to distinguish specific membranes among the bulk of
intracellular membranes and, thus, to contribute to spa-
tially restricting the protein inside the cell. This also sug-
gests that high curvature cannot be the only parameter
controlling its recruitment in vivo [17]. The ALPS motif
was originally identified in the ArfGAP1 protein and pro-
posed to interact with membranes by inserting hydropho-
bic residues into open spaces between lipid chains caused
by the high curvature. Recently, it has been shown that
ArfGAP1 actually contains two ALPS motifs that contrib-
ute to Golgi targeting [18,28-30]. From amino acid
replacement experiments it has been proposed that mod-
erate lipid disorder at the target membrane, such as that
which may exist at the rims of the cisternae, would be
enough for ALPS binding [30]. This is compatible with the
distribution of the GMAP210 N-terminal domain at the
periphery of NZ-induced Golgi ministacks (see Figure 5),
and also with binding to membrane structures that con-
nect Golgi stacks. In this regard, we have detected the pres-
ence of GMAP210 N-terminus in structures connectingBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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The N-terminus and the C-terminus of GMAP210 bind different regions of the Golgi ribbon Figure 5
The N-terminus and the C-terminus of GMAP210 bind different regions of the Golgi ribbon. (A to C) Nter-
DsRed (1–375 aas) and GFP-Cter (1778–1979 aas) constructs were co-transfected in RPE1 cells and their distribution analysed 
by confocal microscopy (A) or deconvolution (B, C). Merged images of the two constructs (A) or of the two constructs with 
giantin (B) or with endogenous GMAP210 (C) immunolocalisation are shown. High magnifications of the selected regions in (A) 
and (B) show individual labellings and the merge. Arrows indicate identical locations for each panel. (D) RPE1 cells co-trans-
fected with Nter-DsRed and GFP-Cter and treated with BFA. All GFP-Cter becomes cytosolic except at the centrosome 
(arrow). (E, F) Time-lapse analysis of RPE1 cells transiently transfected with Nter-DsRed and GFP-Cter in control conditions 
or after nocodazole treatment. Selected frames of Movies 3 (control) or 4 (nocodazole) (see Additional files 3 and 4, respec-
tively) are shown at the same time points. At right, enlarged views of selected areas are shown. (G) RPE1 cells transfected with 
a truncated mutant consisting of both N- and C-termini expressed in fusion (Nter-Cter-GFP, G1) and double labelled for 
endogenous GMAP210 (G2). A merged image is shown in G3. In (H), a Nter-Cter-GFP transfected cell was treated with noc-
odazole and triple labelled for endogenous GMAP210 and Golgin245. High magnifications of the selected region at right show 
individual labellings and the merge. Arrows indicate identical localisation of the truncated mutant and the endogenous protein 
in isolated Golgi ministacks. Bars = 5 μm.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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membranes elements that contain: (i) the cis-Golgi pro-
tein GM130, (ii) the C-terminus of GMAP210 that was
demonstrated to be evenly distributed throughout the cis-
cisternae of Golgi stacks, (iii) the membrane-anchoring
signal peptide of the galactosyltransferase that targets the
GFP to the transmedial region of the GA. These data
strongly support the possibility that the N-terminus of
GMAP210 binds the connecting structures between Golgi
stacks.
What is sensed by the ALPS motif in membranes besides
lipid packing defects remains unknown, but the fact that
it also localises to ER exit sites suggests a common feature.
It has been reported that pre- and early GA compartments
share a high content of PtdIns(4)P and low levels of cho-
lesterol [31]. Localised PtdIns(4)P formation at ERES has
also been described, supporting the possibility that ERES
lipid composition resembles that of cis-Golgi rather than
that of bulk ER [13,31,32]. Interestingly, GMAP210 Dro-
sophila homolog appears associated with both cis-GA and
ERES [23].
The full-length GMAP210 is known to redistribute at
ERES upon BFA treatment like other cis-Golgi matrix pro-
teins [10]. We have observed that all GA-associated ALPS-
containing truncation mutants localised at ERES, not only
upon BFA action but also in control conditions. On the
contrary, mutants lacking this sequence, such as C-termi-
nus-containing constructs, became cytosolic in the pres-
ence of BFA. Thus, the ability of ALPS motif to recognise
ERES might be responsible for the redistribution of
endogenous GMAP210 to these structures in response to
BFA. Others have shown that a variety of cis-Golgi matrix
proteins moved directly to ERES in the tip of BFA-induced
membrane tubules [33]. The matrix proteins remained at
and around the ER exit sites, whereas the trailing trans-
membrane proteins entered the ER at these sites and then
redistribute throughout the ER. Our finding that
GMAP210 ALPS motif associates with ERES in all condi-
tions is the first hint as to how these retrograde membrane
tubules could be targeted to ER membranes.
A second cis-Golgi binding signal is present in the C-ter-
minal domain of GMAP210. Binding of the C-terminus to
liposomes was recently shown to be dependent on ARF1-
GTP and to involve the GRAB domain [15]. Since Arf1
localises throughout the GA stacks [34], specific recruit-
ment of the GFP-Cter construct to the cis-GA in vivo was
unexpected and suggests the involvement of additional
factors that remain to be characterised.
In addition to the cis-GA, the GFP-C-terminal construct
was targeted to the centrosome in RPE1 cells whereas the
full-length protein has never been observed at the centro-
some [12,13]. We hypothesised that the behaviour of this
truncated mutant reflects its affinity for the minus ends of
MTs. In support of this view, the C-terminal domain was
able to displace the minus-end binding protein ninein
from the centrosome, suggesting a competition of both
proteins for MT minus ends (not shown), as previously
reported with another centrosomal protein [12]. Moreo-
ver, we have found that RPE1 cells are unable to form
aggresomes at the centrosome even after extensive treat-
ment with the proteasome inhibitor MG132 (our unpub-
lished data).
The GRAB domain was identified on the basis of its
homology with the GRIP domain, an Arl1-interacting
motif present in several coiled-coil proteins associated
with the trans-GA. Interestingly, the subcellular distribu-
tion of the GRIP-containing protein Cbs in developing
Drosophila varies during the cell division cycle from GA to
chromosomes and centrosomes in the mitotic spindle
[35]. This pattern dramatically changes in the absence of
Drosophila  Arl1 ortholog suggesting that localisation
depends on the GRIP/Arl1 interaction. Indeed, a GFP-
GRIP fusion peptide from Cbs was addressed to centro-
somes and mitotic spindle and interfered with centro-
some function. We have also observed that the C-terminal
domain is present in the poles of mitotic spindles (not
shown).
Depletion of GMAP210 induces fragmentation of the
Golgi ribbon in isolated stacks that lost their pericentro-
somal localisation but maintain normal secretion activity.
This phenotype is reminiscent of that produced by MT
depolymerisation and argues against a critical role of
GMAP210 in protein transport. Instead, it provides sup-
port to our previous proposal that GMAP210 participates
in Golgi ribbon formation around the centrosome.
Depolymerisation of MTs is sufficient to generate mini-
stacks indicating that Golgi ribbon structure normally
undergoes dynamic lateral fusion processes depending on
intact MTs. Data presented here support a model in which
GMAP210 would participate in homotypic fusion of cis-
cisternae by anchoring the surface of cisternae via its C-ter-
minus and projecting its distal N-terminus to bind the
rims or to stabilise tubular structures connecting neigh-
bouring cis-cisternae. When fully extended, the long
coiled-coil central domain of GMAP210 may achieve a
length of approximately 200 nm, which might favour the
tethering between cisternae. As a matter of fact, very short
treatments with nocodazole (NZ), which was not yet pro-
ducing Golgi scattering, induced a specific destabilisation
of GMAP210 containing membranes that could corre-
spond to MT-dependent intersaccular connections [10].
This model also agrees, to a large extent, with the molecu-
lar model proposed from in vitro studies [15], although
the ALPS motif in vivo binds curved intra-Golgi mem-
branes rather than vesicles.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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Contribution of both Golgi binding domains to the localisation of GMAP210 Figure 6
Contribution of both Golgi binding domains to the localisation of GMAP210. (A) Schematic representation of the 
full-length GMAP210 protein and of the truncated mutants used in this experiment. The ALPS-like motif is represented in red, 
coiled-coil regions in light blue, and the predicted GRAB domain in green. Western blot of all of these constructs expressed in 
RPE1 cells is presented in (F). (B) Cells expressing the mutant lacking the N-terminal domain (GFP-GMAPΔN (251–1979 aas)) 
were stained for GM130 (B2) and Golgin245 (B3). Insets show enlarged views. Fluorescence intensity profiles at the bottom 
revealed perfect co-localisation of this mutant with the cis-Golgi marker GM130. (C) Cells transfected with the mutant lacking 
the C-terminal domain (GFP-GMAPΔC (1–1778 aas)) were processed as above. Although the mutant mostly associated with 
the cis-side of the GA, it was also present in areas that did not contain GM130. In addition, it also accumulates in some tubular 
and vesicular structures devoid of GM130. (D, E) The central coiled-coil domains do not contain Golgi targeting information. 
Cells expressing the GFP-GMAPCC1 (D) or GFP-GMAPCC2 fusion proteins and labelled for GM130 are shown. Bars = 5 μm.BMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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The ability of GMAP210 to favour homotypic connection
between stacks, coupled to its capacity to bind MT-minus
ends, could provide a rationale to the recently reported
capacity of GMAP210 to dock IFT20 on the GA [26]. Dur-
ing the transition from the centriole-based centrosome of
cycling cells to the basal body-based primary cilium of
post-mitotic cells, GMAP210 could re-orient part of the
tethering and fusion processes from the cis face of the GA
toward the basal body, mediating the coupling between
axoneme assembly and ciliary membrane fusion and
growth necessary to set the primary cilium as a new cell
compartment.
Conclusion
The Golgi localisation of GMAP210 is the result of the
combined action of two distinct cis-membrane binding
motifs that recognise different domains of the cis-GA. The
N-terminal Golgi binding signal is localised at the first 38
residues of the protein corresponding to the ALPS motif, a
lipid-binding module that folds into an α-helix once
bound to curved membranes. It specifically accumulates
at the periphery of cis-Golgi cisternae and in areas con-
necting adjacent stacks. The C-terminal domain, which
includes the GRAB domain, also associates with the cis-
cisternae but its distribution is continuous along the rib-
bon. Our data support a model in which GMAP210
would participate in homotypic fusion of cis-cisternae by
anchoring the surface of cisternae via its C-terminus and
projecting its distal N-terminus to bind the rims or to sta-
bilise tubular structures connecting neighbouring cis-cis-
ternae. In agreement with this model, depletion of
GMAP210 induces fragmentation of the Golgi ribbon in
isolated stacks that have lost their pericentrosomal locali-
sation [9,13].
Methods
Antibodies
The autoimmune sera against GMAP210 and Golgin-245
(unpublished data) have been previously characterised.
Rabbit anti-GMAP210 (RM130), rabbit anti-ninein poly-
clonal and mouse CTR433 monoclonal antibody have
been produced and purified in our laboratories. Mono-
clonal antibody against giantin was kindly provided by
HP Hauri (University of Basel/Switzerland). Monoclonal
anti-GM130 and anti-Sec31 antibodies were from BD Bio-
sciences (Erembodegen, Belgium) and polyclonal anti-
giantin from Abcam (Cambrige, UK). Nocodazole (10
μM) and Brefeldin A (5 μg/ml) were purchased from
Sigma (Madrid, Spain). Oligofectamine reagent and Lipo-
fectamine 2000 reagent were from Invitrogen (Barcelona,
Spain).
Cell culture, cell extracts, electrophoresis and 
immunoblotting
These studies primarily used diploid, telomerase-immor-
talised human retinal pigment epithelial hTERT-RPE1
cells (Clontech, Mountain View, CA, USA), grown in
DMEM-F12 medium. HeLa cells were grown under stand-
ard conditions. To generate a hTERT-RPE1 cell line with a
fluorescent labelled GA, we used the pAcGFP1-Golgi vec-
tor, which encodes a fusion protein consisting of the N-
terminal 81 amino acids of the human beta 1,4-galactos-
yltransferase, a membrane-anchoring signal peptide that
targets the protein to the transmedial region of the GA,
directly upstream of the green fluorescent protein from
Aequorea coerulescens (GTTM-GFP). To improve the effi-
ciency of selection, this sequence was subcloned into the
bi-cistronic pIRESneo vector. The new construct was trans-
fected in hTERT-RPE1 cells by using Lipofectamine and
then selected with G418 for 4 to 6 weeks. Finally, cell pop-
ulation was sorted in a BD FACSaria cell-sorting system
and only cells expressing high levels of the protein were
maintained. Cell extract preparation, SDS-PAGE and
immunoblotting procedures have been described previ-
ously [12].
Molecular biology, transfection and siRNA
Truncated mutants were constructed in pGFP-C, pGFP-N
or pDsRed-Express-N vector series by subcloning using
internal sites or by PCR. All constructions were verified by
sequencing. To rule out that the effect of small construct
involving the amphipathic helix was due to adjacent
sequences, different linkers were used. Sequences of GFP
(in bold)-fusion proteins involving the amphipathic helix
(italics) were as follows:
ALPS-GFPa:  MSSWLGGLGSGLGQSLGQVGGSLASLT-
GQISNFTKDMLSTVPRARDPPVAT
MVS
ALPS-GFPb:  MSSWLGGLGSGLGQSLGQVGGSLASLT-
GQISNFTKDMLDPPVATMVS...;
ALPS2-GFP:MSSWLGGLGSGLGQSLGQVGGSLASLT-
GQISNFTKDMLSTVPMSSWLGGLG
SGLGQSLGQVGG SLASLTGQISNFTKDMLPPVATMVS...;
ALPS-CC(10pt)-
GFP:MSSWLGGLGSGLGQSLGQVGGSLASLTGQISNFTK-
DMLSTLQQALS
DAENEIMRLSSLNQDNSLAEDNLKLKMRIEVLEKEKSLLS
QEKEELQMSLLKLNNEYEVIKSTATRDISLDSELHDLRLNL
EKEQELNQSISEKETLIAEIEELDRQNQEATKHMILIKDQL
SKQQNEGDSIISKLKQDLNDEKKRVHQLEDDKMDITKE
LDVQKEKLIQSEVALNDLHLTKQKLEDKVENLVDQLNKS
QESNVSIQKENLELKEHIRQNEEELSRIRNELMQSLKDPP-
VATMVS...
RPE1 cells were transfected with Lipofectamine 2000 rea-
gent and processed for IF 6 to 20 h after transfection. CellsBMC Biology 2009, 7:56 http://www.biomedcentral.com/1741-7007/7/56
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were also transfected with small interfering RNA (siRNA)
duplexes (Sigma, Madrid, Spain) and Oligofectamine
according to the manufacturer's instructions. The
sequence of the siRNA specific for the C-terminus of
GMAP210 was 5'-UCAGCGUCAUGAAGUGUUA-3'. The
sequence of the siRNA specific for the N-terminus of
GMAP210 was 5'-GAAUGUCUUGCUGGUAACA-3'. After
48 or 72 h, cells were transfected with the Nter-GFP or the
GFP-Cter constructs, incubated for an additional 16 h and
then processed by IF.
Immunofluorescence and live cell imaging
For immunofluorescence experiments, cells were grown
on 12 to 15 mm round coverslips. Cells were fixed in 4%
PFA during 10 min in PBS pH 7.4, permeabilised in PBS
and 0.5% Triton and then labelled with appropriate anti-
bodies. Cells were examined under a motorised upright
wide-field microscope (Leica DM6000B) equipped for
image deconvolution. Acquisition was performed at room
temperature using an oil immersion objective (63× APO
PL HCX 1.4 NA) and a cooled CCD camera (Leica
DFC35FX). For confocal imaging, the samples were exam-
ined under a Leica SP5 confocal microscope. Optical sec-
tions were obtained with a 63× oil immersion objective
(1.4 NA) at a definition of 1024 × 1024 pixels. For imag-
ing of the fluorescent proteins in living cells, the trans-
fected cells grown on coverslips were placed in a 37°C
incubation chamber attached to a Leica DM6000B motor-
ised microscope and filled with OptiMEM medium.
Acquisition was performed using an oil immersion objec-
tive (63× APO PL HCX, 1.4 NA) and a cooled Hamma-
matsu camera. Z-positioning was accomplished by a
piezo-electric motor. All images correspond to an optical
section unless otherwise stated. Image analysis and 3D
blind deconvolution was performed using the Leica and
Adobe Photoshop and ImageJ 1.42j software. To obtain
the intensity values along a given line, images were proc-
essed with Metamorph Offline 7.1.7.0 using the com-
mand linescan. To obtain a numerical measure of Golgi
binding affinities of ALPS-CC-GFP or 1–76CC-GFP
mutants, we determined the relative fluorescent intensi-
ties over the Golgi and the cytoplasm using the linescan
function of the Metamorph software. Ten lines, contain-
ing 200 pixels each, were drawn at the Golgi or cytoplasm
areas, respectively. Ten cells of each mutant were ana-
lysed.
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